keyword
MENU ▼
Read by QxMD icon Read
search

Hypertension angiotensin renin sodium retention salt

keyword
https://www.readbyqxmd.com/read/27836073/changes-in-the-renin-angiotensin-aldosterone-system-in-response-to-dietary-salt-intake-in-normal-and-hypertensive-pregnancy-a-randomized-trial
#1
Lise H Nielsen, Per Ovesen, Mie R Hansen, Steven Brantlov, Bente Jespersen, Peter Bie, Boye L Jensen
It was hypothesized that primary renal sodium retention blunted the reactivity of the renin-angiotensin-aldosterone system to changes in salt intake in preeclampsia (PE). A randomized, cross-over, double-blinded, dietary intervention design was used to measure the effects of salt tablets or placebo during low-salt diet in PE patients (n = 7), healthy pregnant women (n = 15), and nonpregnant women (n = 13). High-salt intake decreased renin and angiotensin II concentrations significantly in healthy pregnant women (P < ...
November 2016: Journal of the American Society of Hypertension: JASH
https://www.readbyqxmd.com/read/27754015/br-04-1management-of-treatment-resistant-hypertension
#2
David John Webb
Treatment-resistant hypertension (TRH) is defined as the failure to achieve an office BP target of <140/90 mmHg (<130/80 mmHg in patients with chronic kidney disease (CKD) or diabetes) in patients with hypertension (HT), despite adherence to at least 3 antihypertensive medications at optimal tolerated doses, ideally including a diuretic (Calhoun et al., Circulation 2008). TRH identifies patients with hard-to-treat HT, who might benefit from specialist investigation and treatment. Although some studies put the prevalence of TRH as >10%, these levels may be inflated by white-coat hypertension and poor adherence...
September 2016: Journal of Hypertension
https://www.readbyqxmd.com/read/27642926/br-04-1management-of-treatment-resistant-hypertension
#3
David John Webb
Treatment-resistant hypertension (TRH) is defined as the failure to achieve an office BP target of <140/90 mmHg (<130/80 mmHg in patients with chronic kidney disease (CKD) or diabetes) in patients with hypertension (HT), despite adherence to at least 3 antihypertensive medications at optimal tolerated doses, ideally including a diuretic (Calhoun et al., Circulation 2008). TRH identifies patients with hard-to-treat HT, who might benefit from specialist investigation and treatment. Although some studies put the prevalence of TRH as >10%, these levels may be inflated by white-coat hypertension and poor adherence...
September 2016: Journal of Hypertension
https://www.readbyqxmd.com/read/26927805/the-role-of-aldosterone-in-obesity-related-hypertension
#4
REVIEW
Wakako Kawarazaki, Toshiro Fujita
Obese subjects often have hypertension and related cardiovascular and renal diseases, and this has become a serious worldwide health problem. In obese subjects, impaired renal-pressure natriuresis causes sodium retention, leading to the development of salt-sensitive hypertension. Physical compression of the kidneys by visceral fat and activation of the sympathetic nervous system, renin-angiotensin systems (RAS), and aldosterone/mineralocorticoid receptor (MR) system are involved in this mechanism. Obese subjects often exhibit hyperaldosteronism, with increased salt sensitivity of blood pressure (BP)...
April 2016: American Journal of Hypertension
https://www.readbyqxmd.com/read/25482671/urinary-serine-proteases-and-activation-of-enac-in-kidney-implications-for-physiological-renal-salt-handling-and-hypertensive-disorders-with-albuminuria
#5
REVIEW
Per Svenningsen, Henrik Andersen, Lise H Nielsen, Boye L Jensen
Serine proteases, both soluble and cell-attached, can activate the epithelial sodium channel (ENaC) proteolytically through release of a putative 43-mer inhibitory tract from the ectodomain of the γ-subunit. ENaC controls renal Na(+) excretion and loss-of-function mutations lead to low blood pressure, while gain-of-function mutations lead to impaired Na(+) excretion, hypertension, and hypokalemia. We review an emerging pathophysiological concept that aberrant glomerular filtration of plasma proteases, e.g...
March 2015: Pflügers Archiv: European Journal of Physiology
https://www.readbyqxmd.com/read/25377913/the-discovery-of-hypertension-evolving-views-on-the-role-of-the-kidneys-and-current-hot-topics
#6
REVIEW
Richard J Johnson, Miguel A Lanaspa, L Gabriela Sánchez-Lozada, Bernardo Rodriguez-Iturbe
Primary hypertension is increasingly common and is associated with significant morbidity. Here, we review the history of its discovery and rise during the last century with an emphasis on studies trying to identify its cause. Early studies identified a defect in sodium excretion by the kidney as being central to the pathogenesis. Recent studies have focused on a variety of genetic, congenital (fetal programming), and acquired mechanisms for causing the defect in natriuresis. Certain risk factors are apparent, including genetic polymorphisms that regulate sodium excretion, a congenital reduction in nephron number, obesity and hyperleptinemia, an elevated sympathetic nervous system, diet (salt and fructose), and metabolic (hyperuricemia) mechanisms...
February 1, 2015: American Journal of Physiology. Renal Physiology
https://www.readbyqxmd.com/read/24944031/pathophysiology-diagnosis-and-treatment-of-mineralocorticoid-disorders
#7
REVIEW
Steven B Magill
The renin-angiotensin-aldosterone system (RAAS) is a major regulator of blood pressure control, fluid, and electrolyte balance in humans. Chronic activation of mineralocorticoid production leads to dysregulation of the cardiovascular system and to hypertension. The key mineralocorticoid is aldosterone. Hyperaldosteronism causes sodium and fluid retention in the kidney. Combined with the actions of angiotensin II, chronic elevation in aldosterone leads to detrimental effects in the vasculature, heart, and brain...
July 2014: Comprehensive Physiology
https://www.readbyqxmd.com/read/23515616/rats-with-adenine-induced-chronic-renal-failure-develop-low-renin-salt-sensitive-hypertension-and-increased-aortic-stiffness
#8
Lisa Nguy, Maria E Johansson, Elisabeth Grimberg, Jaana Lundgren, Tom Teerlink, Mattias Carlström, Jon O Lundberg, Holger Nilsson, Gregor Guron
Rats with adenine-induced chronic renal failure (A-CRF) develop metabolic and cardiovascular abnormalities resembling those in patients with chronic kidney disease. The aim of this study was to investigate the mechanisms of hypertension in this model and to assess aortic stiffness in vivo. Male Sprague-Dawley rats were equipped with radiotelemetry probes for arterial pressure recordings and received either chow containing adenine or normal control diet. At 7 to 11 wk after study start, blood pressure responses to high NaCl (4%) diet and different pharmacological interventions were analyzed...
May 1, 2013: American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
https://www.readbyqxmd.com/read/22699378/corin-a-key-protein-of-an-adaptive-renal-mechanism-to-respond-to-salt-variation
#9
COMMENT
Richard Bouley
The protease corin generates atrial natriuretic peptide and affects blood pressure and salt-water homeostasis. Under dietary salt challenge, corin knockout mice show blood pressure exacerbation and significant weight gain due to water and salt retention. This phenotype involves the epithelial sodium channel but is independent of the renin-angiotensin-aldosterone system. This suggests that corin has an important role in a new adaptive mechanism of the response to variations of salt in the diet.
July 2012: Kidney International
https://www.readbyqxmd.com/read/22450343/syndromes-of-impaired-ion-handling-in-the-distal-nephron-pseudohypoaldosteronism-and-familial-hyperkalemic-hypertension
#10
REVIEW
Ioannis D Kostakis, Kyriaki G Cholidou, Despina Perrea
The distal nephron, which is the site of the micro-regulation of water absorption and ion handling in the kidneys, is under the control of aldosterone. Impairment of the mineralocorticoid signal transduction pathway results in resistance to the action of aldosterone and of mineralocorticoids in general. Herein, we review two syndromes in which ion handling in the distal nephron is impaired: pseudohypoaldosteronism (PHA) and familial hyperkalemic hypertension (FHH). PHA is a rare inherited syndrome characterized by mineralocorticoid resistance, which leads to salt loss, hypotension, hyperkalemia and metabolic acidosis...
January 2012: Hormones: International Journal of Endocrinology and Metabolism
https://www.readbyqxmd.com/read/21461391/role-of-the-kidneys-in-resistant-hypertension
#11
Z Khawaja, C S Wilcox
Resistant hypertension is a failure to achieve goal BP (<140/90 mm Hg for the overall population and <130/80 mm Hg for those with diabetes mellitus or chronic kidney disease) in a patient who adheres to maximum tolerated doses of 3 antihypertensive drugs including a diuretic. The kidneys play a critical role in long-term regulation of blood pressure. Blunted pressure natriuresis, with resultant increase in extracellular fluid volume, is an important cause of resistant hypertension. Activation of the renin-angiotensin-aldosterone system, increased renal sympathetic nervous system activity and increased sodium reabsorption are important renal mechanisms...
2011: International Journal of Hypertension
https://www.readbyqxmd.com/read/21263123/angiotensinergic-signaling-in-the-brain-mediates-metabolic-effects-of-deoxycorticosterone-doca-salt-in-c57-mice
#12
Justin L Grobe, Beth A Buehrer, Aline M Hilzendeger, Xuebo Liu, Deborah R Davis, Di Xu, Curt D Sigmund
Low-renin hypertension accounts for ≈ 25% of essential hypertensive patients. It is modeled in animals by chronic delivery of deoxycorticosterone acetate and excess dietary sodium (the DOCA-salt model). Previous studies have demonstrated that DOCA-salt hypertension is mediated through activation of the brain renin-angiotensin system. Here, we demonstrate robust metabolic phenotypes of DOCA-salt treatment. Male C57BL/6J mice (6 to 8 weeks old) received a subcutaneous pellet of DOCA (50 mg for 21 days) and were offered a 0...
March 2011: Hypertension
https://www.readbyqxmd.com/read/20444953/salt-sensitivity-is-associated-with-insulin-resistance-sympathetic-overactivity-and-decreased-suppression-of-circulating-renin-activity-in-lean-patients-with-essential-hypertension
#13
Midori S Yatabe, Junichi Yatabe, Minoru Yoneda, Tsuyoshi Watanabe, Makoto Otsuki, Robin A Felder, Pedro A Jose, Hironobu Sanada
BACKGROUND: The mechanisms by which a derangement of glucose metabolism causes high blood pressure are not fully understood. OBJECTIVES: This study aimed to clarify the relation between salt sensitivity of blood pressure and insulin resistance, which are important subcharacteristics of hypertension and impaired glucose metabolism, respectively. Effects on the renin-angiotensin and sympathetic nervous systems were also studied. DESIGN: The state of glucose metabolism was assessed by a hyperinsulinemic euglycemic glucose clamp technique and a 75-g oral-glucose-tolerance test in 24 essential hypertensive patients who were lean and without diabetes or chronic kidney disease...
July 2010: American Journal of Clinical Nutrition
https://www.readbyqxmd.com/read/20414637/effects-of-the-peroxisome-proliferator-activated-receptor-ppar-gamma-agonist-pioglitazone-on-renal-and-hormonal-responses-to-salt-in-diabetic-and-hypertensive-individuals
#14
RANDOMIZED CONTROLLED TRIAL
A Zanchi, M Maillard, F R Jornayvaz, M Vinciguerra, P Deleaval, J Nussberger, M Burnier, A Pechere-Bertschi
AIMS/HYPOTHESIS: Glitazones are powerful insulin sensitisers prescribed for the treatment of type 2 diabetes. Their use is, however, associated with fluid retention and an increased risk of congestive heart failure. We previously demonstrated that pioglitazone increases proximal sodium reabsorption in healthy volunteers. This study examines the effects of pioglitazone on renal sodium handling in individuals prone to insulin resistance, i.e. those with diabetes and/or hypertension. METHODS: In this double-blind randomised placebo-controlled four-way crossover study, we examined the effects of pioglitazone (45 mg daily during 6 weeks) or placebo on renal, systemic and hormonal responses to changes in sodium intake in 16 individuals, eight with type 2 diabetes and eight with hypertension...
August 2010: Diabetologia
https://www.readbyqxmd.com/read/20093814/aldosterone-in-uremia-beyond-blood-pressure
#15
REVIEW
Eberhard Ritz, Nadezda Koleganova
Aldosterone was in the past considered only as a prohypertensinogenic agent. It has recently become clear that apart from the classical endocrine action, i.e. causing blood pressure elevation as a result of salt retention, aldosterone has numerous blood-pressure-independent actions on nonepithelial tissue. Under conditions of high salt concentration, aldosterone is injurious to the kidney, heart and vasculature. Of particular interest are recent observations that aldosterone is a permissive factor for the effect of minor increases in plasma sodium concentration on endothelial cell dysfunction...
2010: Blood Purification
https://www.readbyqxmd.com/read/19249443/sleep-apnea-aldosterone-and-resistant-hypertension
#16
REVIEW
Eduardo Pimenta, David A Calhoun, Suzanne Oparil
Obstructive sleep apnea, aldosterone excess, and resistant hypertension are common comorbidities in obese patients. The mechanisms that link these conditions are not fully elucidated, but sympathetic nervous system activation, sodium retention, renin-angiotensin-aldosterone system stimulation, endothelial dysfunction, and increased production of reactive oxidative species may be contributing factors. Patients diagnosed with this triad should be treated with low-salt diet, weight-loss counseling, and continuous positive airway pressure, as well as aggressive antihypertensive therapy, usually with multiple agents, including a mineralocorticoid receptor antagonist...
March 2009: Progress in Cardiovascular Diseases
https://www.readbyqxmd.com/read/19190681/mechanisms-of-tubular-volume-retention-in-immune-mediated-glomerulonephritis
#17
Juliane Gadau, Harm Peters, Christian Kastner, Hartmut Kühn, Melina Nieminen-Kelhä, Dmytro Khadzhynov, Stephanie Krämer, Hayo Castrop, Sebastian Bachmann, Franziska Theilig
Glomerulonephritis is characterized by hematuria, proteinuria, hypertension, and edema, but the mechanisms contributing to volume disorders are controversial. Here we used the rat anti-Thy1 model of mesangioproliferative glomerulonephritis to test the hypothesis that disturbed salt and water homeostasis is based on tubular epithelial changes that cause salt retention. In this model there was an early onset of pronounced proteinuria and lipiduria associated with reduced fractional sodium excretion and a lowering of the renin-angiotensin-aldosterone system...
April 2009: Kidney International
https://www.readbyqxmd.com/read/18784261/combined-knockout-of-collecting-duct-endothelin-a-and-b-receptors-causes-hypertension-and-sodium-retention
#18
Yuqiang Ge, Alan Bagnall, Peter K Stricklett, David Webb, Yuri Kotelevtsev, Donald E Kohan
The collecting duct (CD) endothelin (ET) system regulates blood pressure (BP) and Na excretion. CD-specific knockout (KO) of ET-1 causes hypertension, CD-specific KO of the ETA receptor does not alter BP, while CD-specific KO of the ETB receptor increases BP to a lesser extent than CD ET-1 KO. These findings suggest a paracrine role for CD-derived ET-1; however, they do not exclude compensation for the loss of one ET receptor by the other. To examine this, mice with CD-specific KO of both ETA and ETB receptors were generated (CD ETA/B KO)...
December 2008: American Journal of Physiology. Renal Physiology
https://www.readbyqxmd.com/read/18437332/aldosterone-in-salt-sensitive-hypertension-and-metabolic-syndrome
#19
REVIEW
Toshiro Fujita
Metabolic syndrome, which is caused by obesity, is now a global pandemic. Metabolic syndrome is an aggregation of hypertension, diabetes and dyslipidaemia. Insulin resistance is a key factor in the development of these components of metabolic syndrome. Concerning the mechanism for the development of hypertension in metabolic syndrome, the lack of insulin resistance in the kidney increases sodium reabsorption by hyperinsulinaemia, leading to sodium retention in the body, and resultant salt-sensitive hypertension...
June 2008: Journal of Molecular Medicine: Official Organ of the "Gesellschaft Deutscher Naturforscher und Ärzte"
https://www.readbyqxmd.com/read/18300843/pathogenesis-of-essential-hypertension-historical-paradigms-and-modern-insights
#20
REVIEW
Richard J Johnson, Dan I Feig, Takahiko Nakagawa, L Gabriela Sanchez-Lozada, Bernardo Rodriguez-Iturbe
Since its first identification in the late 1800s, a variety of etiologies for essential hypertension have been proposed. In this paper we review the primary proposed hypotheses in the context of both the time in which they were proposed as well as the subsequent studies performed over the years. From these various insights, we propose a current paradigm to explain the renal mechanisms underlying the hypertension epidemic today. Specifically, we propose that hypertension is initiated by agents that cause systemic and intrarenal vasoconstriction...
March 2008: Journal of Hypertension
keyword
keyword
18491
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"